Ig replacement therapy ‘beneficial’ for patients with blood cancers
Immunoglobulin replacement therapy is associated with reductions in hypogammaglobulinaemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukaemia or non-Hodgkin’s…